metabolic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Abdominal girth >= 85cm (male) or 90 cm (female) or BMI >= 25 2)Fasting blood glucose level >= 100 mg/dl or HbA1c >=5.6% 3)Systolic blood pressure >= 130 mmHg or diastolic blood pressure >= 85 mmHg 4)Fasting triglyceride level >= 150 mg/dl or HDL-C < 40 mg/dl
Exclusion criteria
Exclusion criteria: 1)Diabetic patients receiving more than 1/2 of the maximum insurable dose of sulfonylurea 2)Diabetic patients receiving more than 25 units of injectable insulin per day 3)Type 1 diabetics or diabetics with insulin dependent conditions patients 4)Patients who started a new or increased dose of diabetes medication within 3 months of obtaining consent 5)Patients who started a new or increased dose of hypertension medication within 3 months of obtaining consent 6)Patients who started a new or increased dose of a hyperlipidemic drug within 3 months of obtaining consent 7)Patients who are pregnant, lactating, possibly pregnant, or expecting 8)Patients who have a malignancy or a history of malignant treatment within 12 months of obtaining consent 9)Other patients who are deemed inappropriate by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Risk values for developing diabetes by using the diabetes risk prediction tool(J-ECOH study) | — |
Countries
Japan
Contacts
Flexible inc CEO